Patent US4082507A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4082507A Expired / Lapsed US ⏱️ 0.0 years remaining

Prosthesis and method for making the same

Assignee: Interface Biomedical Laboratories Corp
•
Filing: 1976-05-10
•
Granted: 1978-04-04
•
Expires: 1996-05-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method is provided for controlling thrombogenicity of a vascular graft prosthesis by controlling the surface charge of at least the intimal surface of the prosthesis by reaction with a compound selected from the group consisting of albumin, glyoxals, ethoxyformic anhydride, formic acid, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide and the like. The surface charge is then stabilized by treatment with glutaraldehyde, dialdehyde starch, formalin or the like.

Inventors

  • 👤 Philip N. Sawyer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 20:10
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/14; A61L27/22; A61L27/24; A61L33/00; A61L33/0076; A61L33/0082; A61F; A61F2310/00; A61F2310/00005; A61F2310/00365; Y; Y10; Y10S; Y10S623/00; Y10S623/92; Y10S623/921

Claims Analysis

Total Claims: 26
Claim 1
Independent Claim 74 words
A method for controlling thrombogenicity of a graft prosthesis comprising making a prosthesis selected from the group consisting of (a) collagen and (b) collagen prepared from ficin digested chemically modified artery or vein material and controlling the surface charge of the intimal surfaces of said prosthesis by reaction with a solution of a compound selected from the group consisting of bovine or human albumin, succinic anhydride, glyoxals, formic acid, ethoxyformic anhydride and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide.
Claim 2
Independent Claim 74 words
A method for controlling thrombogenicity of a graft prosthesis comprising making a prosthesis selected from the group consisting of (a) collagen and (b) collagen prepared from ficin digested chemically modified artery or vein material and controlling the surface charge of the intimal surfaces of said prosthesis by reaction with a solution of a compound selected from the group consisting of bovine or human albumin, succinic anhydride, glyoxals, formic acid, ethoxyformic anhydride and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide.
Claim 3
Dependent Claim 17 words
A method as claimed in claim 1 comprising stabilizing the surface charge by administering a stabilizing agent.
Claim 4
Dependent Claim 23 words
A method as claimed in claim 2 wherein the stabilizing agent is selected from the group consisting of glutaraldehyde, dialdehyde starch or formalin.
Claim 5
Dependent Claim 19 words
A method as defined in claim 1 wherein the collagen is prepared from ficin digested bovine carotid artery material.
Claim 6
Dependent Claim 16 words
A method as defined in claim 1 wherein the prosthesis is formed as a vascular prosthesis.
Claim 7
Dependent Claim 16 words
A method as defined in claim 1 wherein the prosthesis is formed as a cardiac valve.
Claim 8
Dependent Claim 25 words
A method as defined in claim 1 wherein the graft prosthesis includes amino acids selected from the group consisting of arginine, lysine, hydroxylysine and histidine.
Claim 9
Dependent Claim 8 words
A prosthesis made as defined in claim 1.
Claim 10
Dependent Claim 15 words
A method as defined in claim 1 wherein the collagen is dialdehyde starch tanned collagen.
Claim 11
Independent Claim 40 words
A method for controlling thrombogenicity of a graft prosthesis comprising making a prosthesis of a collagen, increasing the negative surface charge of said prosthesis and stabilizing the surface charge by a glutaraldehyde reaction according to the following chemical reaction: ##STR3##
Claim 12
Independent Claim 40 words
A method for controlling thrombogenicity of a graft prosthesis comprising making a prosthesis of a collagen, increasing the negative surface charge of said prosthesis and stabilizing the surface charge by a glutaraldehyde reaction according to the following chemical reaction: ##STR3##
Claim 13
Independent Claim 25 words
A method for decreasing the thrombogenicity of a vascular graft prosthesis comprising rendering the surface charge of the internal surface of said prosthesis more negative.
Claim 14
Independent Claim 25 words
A method for decreasing the thrombogenicity of a vascular graft prosthesis comprising rendering the surface charge of the internal surface of said prosthesis more negative.
Claim 15
Independent Claim 25 words
A method for increasing the thrombogenicity of a vascular graft prosthesis comprising rendering the surface charge of the internal surface of said prosthesis more positive.
Claim 16
Independent Claim 25 words
A method for increasing the thrombogenicity of a vascular graft prosthesis comprising rendering the surface charge of the internal surface of said prosthesis more positive.
Claim 17
Dependent Claim 32 words
A method as defined in claim 11 wherein said prosthesis has on the internal surface thereof compounds exhibiting a positive charge comprising rendering said positive charge more negative by blocking said compounds.
Claim 18
Dependent Claim 26 words
A method as defined in claim 13 wherein said compounds comprise at least one compound selected from the group consisting of arginine, lysine, hydroxylysine and histidine.
Claim 19
Dependent Claim 18 words
A method as defined in claim 1 wherein the surface charge is controlled by bovine or human albumin.
Claim 20
Dependent Claim 24 words
A method as defined in claim 1 wherein the surface charge of the internal surfaces of said prosthesis is controlled by reaction with glyoxals.
Claim 21
Dependent Claim 25 words
A method as defined in claim 1 wherein the surface charge of the internal surfaces of said prosthesis is controlled by reaction with ethoxyformic anhydride.
Claim 22
Dependent Claim 25 words
A method as defined in claim 1 wherein the surface charge of the internal surfaces of said prosthesis is controlled by reaction with 1-ethyl-3-(3-dimethylamino propyl)carbodiimide.
Claim 23
Dependent Claim 31 words
A method as claimed in claim 1 wherein said prosthesis is a tube, comprising closing off an end of said tube, inserting said solution into said tube, and stirring said solution.
Claim 24
Dependent Claim 14 words
A method as claimed in claim 1 comprising flowing said solution through said tube.
Claim 25
Dependent Claim 23 words
A method as claimed in claim 20 wherein said solution flows through the tube at a rate of 50 ± cc. per minute.
Claim 26
Dependent Claim 24 words
A method as claimed in claim 20 wherein said solution flows through the tube at a rate of one volume ± 20% per minute.

References Cited (Backward Citations)

US2900644A Cited
US3927422A Cited
US3966401A Cited
US3988728A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-04-03 1981-10-03 1982-04-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-04-03 1985-10-03 1986-04-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-04-03 1989-10-03 1990-04-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag